Showing results (171-180 of 206) with videos related to
Sort By:
Pageof 21
Journal of Nanobiotechnology|April 12, 2024
Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19Jia-You Fang, Kuo-Yen Huang, Tong-Hong Wang, et al.Molecular Cancer Therapeutics|March 24, 2012
Multiple antigenic peptides based on H-2K(b)-restricted CTL epitopes from murine heparanase induce a potent antitumor immune response in vivoXu-Dong Tang, Guo-Zhen Wang, Jun Guo, et al.Virology Journal|April 19, 2025
Tradeoffs between proliferation and transmission in virus evolution- insights from evolutionary and functional analyses of SARS-CoV-2Jui-Hung Tai, Ding-Chin Lee, Hsin-Fu Lin, et al.Biophysical Journal|April 14, 2019
Active Transport of Membrane Components by Self-Organization of the Min ProteinsYu-Ling Shih, Ling-Ting Huang, Yu-Ming Tu, et al.Journal of Cardiopulmonary Rehabilitation and Prevention|April 8, 2021
Increasing Walking Speed to Achieve a Pre-training Endurance Shuttle Walk Time of 5-10 min May Improve Test Responsiveness in People With Chronic Obstructive Pulmonary DiseaseKylie Hill, Yan Ling Chao, Vinicius Cavalheri, et al.Mbio|July 27, 2021
D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike CleavageYa-Wen Cheng, Tai-Ling Chao, Chiao-Ling Li, et al.EMBO Molecular Medicine|November 7, 2020
Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infectionKuo-Yen Huang, Ming-Shiu Lin, Ting-Chun Kuo, et al.Pharmaceutics|January 21, 2022
Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple TargetsPei-Chen Yu, Chen-Hao Huang, Chih-Jung Kuo, et al.Microbiology Spectrum|March 16, 2022
Neutralizing Monoclonal Antibodies Inhibit SARS-CoV-2 Infection through Blocking Membrane FusionChia-Jung Li, Tai-Ling Chao, Ting-Yu Chang, et al.Journal of Hematopathology|January 4, 2024
Lineage switch of KMT2A-rearranged adult B-lineage acute lymphoblastic leukemia following bispecific T-cell engager and monoclonal antibody therapyJia-Rong Wu, Pei-Chun Shih, Ching Li, et al.Pageof 21